ClassID:

112184

C12N2795/18134 - CPC Classification

Classification description:

Bacteriophages; Details ssRNA Bacteriophages positive-sense; Leviviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20250302940
2025-10-02

PATHOGEN-LIKE ANTIGEN-BASED VACCINE AND PREPARATION METHOD THEREFOR

#2
20250042962
2025-02-06

COMPOSITIONS TARGETING APOPTOSIS-ASSOCIATED SPECK-LIKE PROTEIN WITH CASPASE ACTIVATION AND RECRUITMENT DOMAIN (ASC) AND METHODS OF USE

#3
20240299512
2024-09-12

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#4
20240279295
2024-08-22

Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use

#5
20240197845
2024-06-20

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#6
20240156937
2024-05-16

BACERIOPHAGE VIRUS-LIKE PARTICLES VACCINES FOR CHLAMYDIA TRACHOMATIS INFECTIONS

#7
20210236608
2021-08-05

Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same

#8
20200261559
2020-08-20

Vaccine and therapeutic compositions comprising antigen-conjugated viral capsids

#9
20190328854
2019-10-31

C5 IMMUNIZATION FOR AUTOLOGOUS ANTI-C5 ANTIBODY PRODUCTION

#10
20190134170
2019-05-09

Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same

#11
20180050097
2018-02-22

IMMUNOTHERAPY COMPOSITIONS AND METHODS FOR TREATMENT OF TAUOPATHY AND TRANSGENIC MOUSE

#12
20170189503
2017-07-06

PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same

#13
20160228525
2016-08-11

Malaria vaccine

#14
20150202281
2015-07-23

Molecular Antigen Array

#15
20120114674
2012-05-10

Molecular Antigen Array

#16
20110305723
2011-12-15

Molecular Antigen Array

#17
20080274131
2008-11-06

Molecular antigen arrary

#18
20070048287
2007-03-01

Molecular antigen array